BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19282767)

  • 1. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
    Xu AM; Xian ZH; Zhang SH; Chen XF
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
    Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
    Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholangiocarcinoma developing in von Meyenburg complexes in haemochromatosis].
    Wisniewski B; Tordjman G; Tran Van Nhieu J; Bettan L; Courillon-Mallet A
    Gastroenterol Clin Biol; 2002 Oct; 26(10):922-4. PubMed ID: 12434102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
    Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
    Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.
    Song JS; Lee YJ; Kim KW; Huh J; Jang SJ; Yu E
    Pathol Int; 2008 Aug; 58(8):503-12. PubMed ID: 18705771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in association with bile duct hamartomas: report on 2 cases and review of the literature.
    Heinke T; Pellacani LB; Costa Hde O; Fuziy RA; Franco M
    Ann Diagn Pathol; 2008 Jun; 12(3):208-11. PubMed ID: 18486898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma arising in association with von-Meyenburg's complexes: an incidental finding or precursor lesions? A clinicopatholigic study of 4 cases.
    Jain D; Nayak NC; Saigal S
    Ann Diagn Pathol; 2010 Oct; 14(5):317-20. PubMed ID: 20850692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma arising in Caroli's disease.
    Phinney PR; Austin GE; Kadell BM
    Arch Pathol Lab Med; 1981 Apr; 105(4):194-7. PubMed ID: 6260057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).
    Röcken C; Pross M; Brucks U; Ridwelski K; Roessner A
    Arch Pathol Lab Med; 2000 Nov; 124(11):1704-6. PubMed ID: 11079031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of cholangiectasis with cholangiocarcinoma].
    Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.
    Luh F; Kuei A; Fann P; Chu P; Yen Y
    Anticancer Res; 2009 Aug; 29(8):3239-43. PubMed ID: 19661341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current problems with intrahepatic bile duct stones in Japan--congenital biliary malformations as a cause.
    Fujii H; Yang Y; Matsumoto Y; Suda K
    Hepatogastroenterology; 1997; 44(14):328-41. PubMed ID: 9164499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.